The BioBay Stem Cell Outlook: Congress to IP
The president of the leading biotech industry organization in the San Francisco Bay Area has a good-news, bad-news position on stem cell research.
The bad news is that the "potential" is more than a decade distant. The good news is that some companies have technology that may bear fruit sooner than the efforts of the California stem cell agency.
Matt Gar…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.